NYSE: CL
Colgate-Palmolive Company
$89.82
▼ -0.93 (-1.02%)as of 2026-08-31
1-year price · 252 sessions
Key stats
52-week range$89.82
$74.98$99.14
Today
- Open
- 90.42
- Day high
- 90.64
- Day low
- 89.81
- Prev close
- 90.75
- Volume
- 5.8M
Valuation
- Mkt cap
- $71.6B
- P/E (TTM)
- 35.3
- EPS (TTM)
- $2.54
- P/B
- 303.4
- P/S
- 3.4
Dividend
- Yield
- 2.34%
- Per share
- $2.10
Insider & institutional activity · SEC Form 4 / 13F
- ▼Insiders net selling -$16.1M over the last 3 months (0 open-market buys, 3 sales)
- 🏛Institutions mixed (13F)
Colgate-Palmolive Company (CL) is a Consumer Defensive company listed on NYSE. The stock is up 7% over the past year. Over the trailing 3 months, insiders filed 0 open-market buys and 3 sales (SEC Form 4). Drillr has 1 published research article covering CL.
Colgate-Palmolive Company (CL) financials & analyst ratings
Fundamentals (TTM)
Margins
Gross margin60.4%
Operating margin20.7%
Net margin9.7%
FCF margin18.3%
Growth & returns
Revenue growth+5.2%
Revenue growth (fwd)+3.2%
EPS growth-28.9%
Return on equity863.1%
Return on assets12.1%
Analyst consensus · 10 analysts
BuyBuy 6Hold 4Sell 0Avg target $99 (+10.3%)Range $87–$110
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
CL earnings date, history & EPS estimates
Next earnings
Oct 30, 2026in NaN days
EPS est $0.92 · Revenue est $5.3B
Track record
Beat EPS in 11 of 12 quarters
Avg surprise +3.5% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Jul 31, 2026 | $0.95 | $0.99 | +4.5% | $5.4B | +0.1% |
| May 1, 2026 | $0.94 | $0.97 | +2.9% | $5.3B | +2.3% |
| Jan 30, 2026 | $0.91 | $0.95 | +4.2% | $5.2B | +2.3% |
| Oct 31, 2025 | $0.89 | $0.91 | +2.2% | $5.1B | +0.2% |
| Aug 1, 2025 | $0.90 | $0.92 | +2.3% | $5.1B | +1.4% |
| Apr 25, 2025 | $0.86 | $0.91 | +6.1% | $4.9B | +0.5% |
| Jan 31, 2025 | $0.90 | $0.91 | +0.9% | $4.9B | -0.9% |
| Oct 25, 2024 | $0.89 | $0.91 | +2.0% | $5.0B | +0.3% |
| Jul 26, 2024 | $0.87 | $0.91 | +4.6% | $5.1B | +0.9% |
| Apr 26, 2024 | $0.81 | $0.86 | +6.2% | $5.1B | +1.9% |
| Jan 26, 2024 | $0.85 | $0.87 | +2.5% | $5.0B | +1.1% |
| Oct 27, 2023 | $0.80 | $0.86 | +7.6% | $4.9B | +2.1% |
CL insider trading activity (SEC Form 4)
Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$16.1M
Insider trades by month Buys Sells
Feb
May
Nov
Feb
May
Aug
Context3-month price +2.3%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 26, 2026 | Tsourapas Panagiotisofficer: COO, CD, EMEA, APac, Skin | Sell | 10,000 | $92.05 |
| Aug 7, 2026 | CAHILL JOHN Tdirector | Option | 4,170 | $71.56 |
| Aug 7, 2026 | CAHILL JOHN Tdirector | Sell | 4,170 | $93.37 |
| Aug 6, 2026 | Wallace Noel R.director, officer: Chairman, President & CEO | Sell | 161,021 | $91.92 |
| Aug 6, 2026 | Wallace Noel R.director, officer: Chairman, President & CEO | Option | 161,021 | $72.29 |
| Jul 2, 2026 | Newman Briandirector | Grant | 209 | $89.45 |
| Jul 2, 2026 | NORRINGTON LORRIE Mdirector | Grant | 293 | $89.45 |
| Jul 2, 2026 | BILBREY JOHN Pdirector | Grant | 265 | $89.45 |
| Jun 17, 2026 | GRANT SHANEofficer: COO, Americas | Tax | 23,347 | $90.66 |
| May 18, 2026 | Malcolm Gregoryofficer: EVP and Controller | Sell | 2,300 | $88.44 |
| May 13, 2026 | NORRINGTON LORRIE Mdirector | Grant | 2,075 | — |
| May 13, 2026 | BILBREY JOHN Pdirector | Grant | 2,075 | — |
| May 13, 2026 | Edwards Lisadirector | Grant | 2,424 | $86.74 |
| May 13, 2026 | Newman Briandirector | Grant | 2,424 | $86.74 |
| May 13, 2026 | HARRIS C MARTINdirector | Grant | 2,424 | $86.74 |
Source: CL SEC Form 4 filings, latest Aug 26, 2026. For informational purposes only — not investment advice.
See the full CL insider & 13F page →Track CL with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free